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Quantitative mass spectrometry-based proteomic assays often suffer from a lack of robustness
and reproducibility. We here describe a targeted mass spectrometric data acquisition strategy
for affinity enriched subproteomes—in our case the kinome—that enables a substantially
improved reproducibility of detection, and improved quantification via isobaric tags. Inclusion
mass lists containing m/z, charge state, and retention time were created based on a set of 80
shotgun-type experiments performed under identical experimental conditions. For each target
protein, peptides were selected according to their frequency of observation and isobaric tag for
relative and absolute quantitation (iTRAQ) reporter ion quality. Retention times of selected
peptides were aligned using similarity driven pairwise alignment strategy yielding 1 min
standard deviation for 4 h gradients. Multiple fragmentation of the same peptides resulted in
better statistics and more precise reporter ion based quantification without any loss in
coverage. Overall, 24% more target proteins were quantified using the targeted data acquisi-
tion approach, and precision of quantification improved by 1.5-fold. We also show that a
combination of higher energy collisional dissociation (HCD) with collisional induced dissoci-
ation (CID) outperformed pulsed-Q-dissociation (PQD) on the OrbitrapXL. With the CID/
HCD based targeted data acquisition approach 10% more quantifiable target proteins were
identified and a 2-fold increase in quantification precision was achieved. We have observed
excellent reproducibility between different instruments, underlining the robustness of the
approach. (J Am Soc Mass Spectrom 2010, 21, 1668–1679) © 2010 American Society for Mass
SpectrometryWhen combined with mass spectrometry, affin-ity enrichment techniques enable the detailedquantitative study of a defined subproteome.
For example, protein complexes can be studied using
either immunoprecipitation or affinity purification
using genetically engineered bait proteins (e.g., TAP
tagged proteins). Moreover, selective enrichment of
post-translationally modified proteins can be achieved,
e.g., ubiquitinated [1] or tyrosine phosphorylated [2]
proteins. When pharmacologically active small mole-
cule compounds are immobilized on a solid support,
these affinity matrices can be employed to characterize
the protein target profile of these compounds directly
from cell or tissue extracts, making this chemical pro-
teomics approach a powerful tool for mode-of action
studies of, e.g., candidate drug molecules (for recent
reviews see: [3–5]). Recently, a variety of chemical
proteomics technologies have emerged that enable
the selective enrichment of enzyme classes, directly
from any cell line or tissue [6–10]. Modern quantita-
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how cellular perturbations like growth factor stimu-
lation or drug treatment impact the affinity captured
subproteomes [11].
Recently, several approaches to selectively enrich for
a large fraction of the human kinome using immobi-
lized nonselective kinase inhibitors or acyl phosphate-
nucleotide analogues were reported [6, 8–10]. A partic-
ularly relevant application of these target class selective
enrichment techniques utilizing the conserved ATP
binding pocket is their application in competition bind-
ing experiments with ATP competitive kinase inhibitor
compounds. In a previous report, we described a pro-
teomic assay utilizing mixed kinase inhibitor beads
(“kinobeads”) for kinome wide profiling of cellular
targets of kinase inhibitor molecules [6]. In a competi-
tion binding assay, binding potencies of ATP-competitive
inhibitor compounds were determined by measuring
relative amounts of affinity-captured kinases as a func-
tion of inhibitor concentration using isobaric tagging for
relative and absolute quantitation (iTRAQ) and mass
spectrometry.
Here, we report that reproducibility of the proteomic
target profiles and precision of protein quantification is
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egy. Based on a dataset of 80 shotgun experiments, we
selected the most suitable peptides for each kinase
likely to be detected under the experimental conditions.
Selection criteria included the frequency of observation
and the quality of the iTRAQ reporter ion signal infor-
mation obtained. We obtained 24% higher kinase cov-
erage and 1.5-fold higher precision by using the
targeted data acquisition approach. Additionally, we
combined the targeted approach with the implementa-
tion of higher energy dissociation (HCD) [12] on the
Orbitrap in combination with collisional induced disso-
ciation (CID), which gave an additional 10% gain in
kinase coverage and a 2-fold gain in precision. We
concur that the inclusion mass list-driven targeted data
acquisition approach of isobarically labeled peptides
will be advantageous for a variety of affinity purifica-
tion based mass spectrometry assays.
Methods
Sample Preparation
Kinase enrichment using mixed kinase inhibitor resins
were performed as described previously in [6]. Briefly,
a 1:1 mixture of Jurkat and Ramos cell lysates was used
at a final protein concentration of 5 mg/mL; 1-mL lysate
aliquots were incubated with 35-L kinobead slurry for
1 h, and bound kinases were eluted after washing using
50-L  2 SDS sample buffer. Samples were run into a
denaturing gel for 20 min to remove reagents incom-
patible with tryptic digestion. Tryptic in-gel digestion
and iTRAQ labeling enrichment were done as described
in [6]. Briefly, reduced and carbamidomethylated kino-
bead eluates were concentrated on 4%–12% -PAGE
gels (Invitrogen, Carlsbad, CA, USA) by running sam-
ple 1 cm into the gel to remove reagents incompatible
with tryptic digestion and iTRAQ labeling. After stain-
ing with colloidal Coomassie, gel lanes were cut into
three slices and subjected to in-gel digestion. Subse-
quently, peptide extracts were labeled with iTRAQ
reagents (Applied Biosystems, Foster City, CA, USA) by
adding 10-L reagent in ethanol and incubation for 1 h
at 20 °C in 60% ethanol, 40 mM triethylammoniumb-
icarbonate, pH 8.53. After quenching of the reaction
with glycine, all labeled extracts of one-gel lane were
combined and mixed with differently labeled extracts.
Reproducibility analyses were performed from a
pooled sample of several competition binding experi-
ments using the described kinase enrichment procedure
[6], and displaying various degrees of displacement for
individual kinases. This sample is referred to as the
“reference sample” in the remainder of the text.
Reference Data for Creation of Inclusion Lists
Results from 80 experiments performed using various
compounds for competition and a 1:1 mixture of Jurkat
and Ramos cell lysates were used to create an initialinclusion list. Peptide data from all experiments includ-
ing reporter ion signal intensities were stored in a
relational database. Parameters that were stored with
each peptide include: Mascot score, experimental reten-
tion time, modifications, charge state, ion accumulation
time for the MS/MS spectrum, and reporter ion areas.
Mass Spectrometry
Experiments were performed on Thermo LTQ Orbitrap
XL and Thermo LTQ Orbitrap Velos [13] mass spec-
trometers that were coupled to split-less Eksigent
NanoLCs (Dublin, CA, USA). Peptides were separated
on a custom made 50 cm  75 uM (ID) reversed-phase
column (Reprosil, Maisch, Germany) and gradient elu-
tion was performed from 2% acetonitrile to 40% aceto-
nitrile in 0.1% formic acid within 4 h using a flow rate
of 250 nL/min. The Orbitrap XL mass spectrometer was
operated using the XCalibur Developers kit 2.0.7. The
Orbitrap Velos mass spectrometer was operated using
the XCalibur Developers kit 2.1.0. Intact peptides were
detected in the Orbitraps at 60,000 resolution. Internal
calibration was performed using the ion signal of
(Si(CH3)2O)6H
 at m/z 445.120025 as a lock mass [14].
Maximal ion accumulation time allowed on the LTQ
Orbitraps was 1 s for MS; automatic gain control was
used to prevent over-filling of the ion trap. No FT
preview scan was used. The minimum MS signal for
triggering MS/MS was set to 1000. PQD settings were
optimized as described in Bantscheff et al. [15]. The
normalized collision energy was set to 29%, Q value
was 0.55, and an activation time of 0.34 ms was used.
HCD settings. Target value FT: 5E4 ions, collision
energy: 70%, maximum FT fill time 500 ms, isolation
width: 2.5 Da. Fragment ions were detected in the
Orbitrap at a resolution of 7500. CID settings: Target
value LTQ: 1e4 ions, max LTQ fill time 100 ms, collision
energy: 35%, isolation width 2.5 Da.
For shotgun experiments up to six PQD sequencing
events on the top six peaks were allowed. Monoisotopic
precursor selection was enabled. Non-peptide monoiso-
topic recognition was not enabled. Charge state rejec-
tion was enabled. Unassigned charge states and charge
state 1 were rejected. Repeat count was set to 1. Exclu-
sion mass width low was set to 1 Da and exclusion mass
width high to 2 Da. Repeat duration was set to 30 s,
exclusion duration was set to 120 s.
Targeted data acquisition. The created inclusion mass
lists were saved in a CSV format, with separate columns
for MS Mass (m/z), Start (min), End (min), and MS
Charge State. Note: The MS charge state information in
the inclusion lists can only be used when the charge
recognition function is switched on. The assigned
charge state of the precursor has then to match the
charge state on the inclusion list to be fragmented. The
m/z values were in column one, Start values in column
two, End values in column three. The files were im-
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only (or four pairs of CID/HCD) sequencing events on
the top six peaks (or top four peaks) matching to m/z
and retention time windows on the inclusion list were
allowed. Monoisotopic precursor selection was enabled.
Non-peptide monoisotopic recognition was not en-
abled. Charge state rejection was enabled. Unassigned
charge states and charge state 1 were rejected. Repeat
count was set to 4. Exclusion mass width low was set to
7.5 ppm and exclusion mass width high to 7.5 ppm.
Repeat duration was set to 30 s; exclusion duration was
set to 120 s. The use of global parent and reject lists was
enabled. The parent mass width was set to 7.5 ppm for
both high and low m/z.
Protein Identification
The acquired raw data were processed with in-house
developed software. MGF files were created and sub-
mitted to the Mascot search engine [16]. The following
settings were used: 7.5 ppm precursor mass accuracy
(monoisotopic mass), 0.8 Da fragment ion mass accu-
racy. The following modifications were selected, vari-
able modifications: oxidation (methionine), iTRAQ
(N-term), acetyl (protein N-term), fixed modifications:
iTRAQ (lysine), carbamidomethyl (cysteine). The in-
strument type was chosen as ESI-TRAP, the enzyme
specificity as Trypsin/P, and the maximum number of
missed cleavages was set to 3. The data were searched
against an in-house curated version of the human
International Protein Index database combined with a
decoy version thereof [17, 18]. Our database contains a
total of 163,476 protein sequences (50% forward, 50%
reverse) and represents a nonredundant composite of
International Protein Index versions 1.0–3.54. It is fur-
ther supplemented with protein sequences of bovine
serum albumin, porcine trypsin, and mouse, rat, and
sheep keratins. Protein identification acceptance criteria
for kinase enriched samples were solely based on
spectrum to peptide sequence assignments that repre-
sented the best match (bold red definition of Mascot)
and had a 10 higher Mascot probability than the
second best match. For protein identifications with only
one single peptide meeting these criteria, we required
the Mascot score to be at least 33. Experiments with a
decoy database indicate a 1% false discovery rate for
protein identification. For identifications where multi-
ple peptides met these criteria, the decoy search results
indicated 0.1% false discovery rate on protein level.
Protein Quantification
Centroided iTRAQ reporter ion signals (114.111 Da,
115.108 Da, 116.112 Da, 117.115 Da) were computed by
the XCalibur software operating the mass spectrometer
and extracted from MS data files using in-house devel-
oped software. Only spectra of peptides unique for
identified proteins were used for relative protein quan-
tification. iTRAQ reporter ion intensities were multi-plied with the ion accumulation time yielding an area
value proportional to the number of reporter ions
present in the ion trap [15]. Fold changes indicating
relative abundancies were calculated using a linear
model in which the iTRAQ intensities of the individual
peptides of two conditions are plotted on the x and y
axis. A straight line, forced to go through the origin,
was fitted to the data. The slope of the line was the
measure for the determined fold change. For each
protein, 3-fold changes were calculated (114 to 117, 115
to 117, and 116 to 117) [15].
For the CID/HCD setup, the iTRAQ reporter ion
signals were extracted from the HCD spectrum and
linked to the corresponding CID spectrum performed
on the same precursor. The fold change ratio calculation
was then performed as described above.
Signal to Interference Calculation
Precursor abundance (PAb) was extracted from the MS
scan performed before the MS/MS event and is the sum
of the integrated ion intensities over the isotope cluster.
Precursor interference at the time of the MS/MS event
was calculated as PAb divided by the sum of all ion
signals observed within the isolation window (summed
up with a weighting of 1 in the 1 Da region of the 12C
peak of the precursor and a weighting of 0.5 in the
regions1 to 1.5 Da and1 to1.5 Da). Consequently,
values close to one indicate little and values close to
0 a high degree of interference caused by co-eluting
components.
Automated RT Alignment
The RT alignment is performed in two iterations. Dur-
ing the first iteration, the last experiment E1 that has
been performed on the instrument is aligned in turn to
all other experiments in the database. The alignment
quality is estimated for each experiment. Before the
second iteration the experiments in the database are
ordered according to decreasing alignment quality.
The E1 experiment is then aligned to each experiment
in the database again and the retention times, peptide
combinations that are present in the database exper-
iment, but not in the E1 experiment, are added after
each alignment.
First Iteration
The alignment procedure uses the last experiment, E1
that was performed on the instrument with the current
LC setup, as a starting point (alignment seed). For each
peptide (unique sequence, modification combination)
that has a Mascot score of above 20, the retention time
corresponding to the earliest sequencing event of this
peptide is selected, RT_E1  {(pep1, rt1), (pep2, rt2), . . . ,
(pepL, rtL)}, pepn are the distinct peptides, rtn are their
retention times divided by the gradient time, and L is
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 20 in E1.
Next the peptide, RT_E1 data is compared with an
experiment in the database, E2. The RT_E2 data is
selected for E2 using the same criteria as for E1. The
retention times that point to the same peptide in
E1 and E2 are paired, RT_E1_E2  {(rt1_e2,rt1_e1),
(rt2_e2,rt2_e1), . . . , (rtM_e2,rtM_e1)} where M is the
number of common peptides. If M  100, an alignment
is performed. This is done by a least-squares fitting of a
fourth order polynomial, P4 to the M (rtn_e2,rtn_e1)
pairs, where rtn_e2 comprise the x coordinates and
rtn_e1 the y coordinates. The aligned retention time
values are obtained by transforming the rtn_e2 values
with P4, obtaining the rtn_e2_P4 values. Subsequently,
the retention time difference vector is calculated, diffV 
[rt_e1- rt_e2_P4, rt_e1- rt_e2_P4, . . . , rt_e1- rt_e2_P4],
the standard deviation of the retention time differences,
StD(diffV) and the median, Med(diffV). Then an outlier
removal step is performed. All rt_e2_P4 values that
deviate by more than 3*StD(diffV) from Med(diffV) are
removed. The alignment is performed again without
the outliers and the recalculated StD(diffV) value is
assigned to E2.
The data from E1 is compared in this way to all the
N-1 experiments, (N total number of experiments), in
the database. In the end N-1 StD(diffV) values are
calculated corresponding to N-1 experiments.
Second Iteration
The N-1 experiments are ordered according to increas-
ing StD(diffV) values, {E2, E3, . . . , EN-1}¡ { E2=, E3=, . . . ,
EN-1=}. The data from E2= is aligned to E1, the outliers
removed and the data realigned again as in the first
iteration. Now the retention times of the peptides with
Mascot score above 20 that are present in E2= but not in
E1 are transformed using the fourth order polynomial
from the second alignment and added to the RT_E1
data, RT_E1  {(pep1, rt1), (pep2, rt2), . . . , (pepL, rtL),
(pepL1, rtL1), . . . , (pepLK, rtLK)}, where K is the
number of added peptide, aligned retention time com-
binations from E2=.
This is repeated for all N-1 experiments. In the last
step the retention times for peptides that are used for
the inclusion list are multiplied with the gradient time
of the planned experiment and matched to the corre-
sponding m/z values. The Start and End times are
calculated by subtracting and adding the desired time
window, t_w from all the retention times on the list,
with the minimum allowed value being 0, and maxi-
mum allowed value being the gradient time.
Results and Discussion
In a previous report, we described a proteomic assay
utilizing mixed kinase inhibitor resins beads (“kino-
beads”) for kinome wide profiling of cellular targets of
kinase inhibitor molecules [6]. In a competition bindingassay binding potencies of ATP-competitive inhibitor
compounds were determined by measuring relative
amounts of affinity-captured precipitated kinases as
function of inhibitor concentration using isobaric pep-
tide tagging (iTRAQ) and quantitative mass spectrom-
etry (iTRAQ) (Figure 1a). Affinities of inhibitor com-
pounds against 100 kinases were determined in one
LC-MS/MS run using pulsed-Q-dissociation (PQD) on
an Orbitrap mass spectrometer operated in shotgun
mode. However, comparison of results obtained for
larger panels of inhibitor molecules is impaired by the
limited reproducibility of target protein identifications
using the shotgun approach (Figure 1b). High mass
accuracy inclusion lists using high-resolution mass
spectrometers have recently been reported as an alter-
native to SRM-based strategies for targeted data acqui-
sition [19, 20] and can be readily combined with isobaric
labeling methods for quantitative mass spectrometry.
To determine the most suitable peptides per kinase,
results from 80 experiments performed under standard-
ized experimental conditions and analyzed on Orbitrap
XL mass spectrometers using PQD in shotgun mode
were uploaded into a relational database (Figure 2).
Peptide retention times were aligned using a two-stage
similarity driven polynomial alignment strategy (see
Materials and Methods section). For each detected
protein, only peptides were considered that were iden-
tified with a Mascot score 20, and were fully iTRAQ
labeled (N-terminus and lys residues), and were unique
for the protein (sequence not shared with other pro-
teins). For each target protein detected peptides were
sorted according to (frequency of detection)(summed
reporter ion area). Peptides detected in several charge
states in the dataset were treated as multiple entities.
The peptides were sorted in descending order accord-
ing to this criterion, and the top 10 peptides were
selected for each protein. For these peptides inclusion
mass lists containing m/z, charge state and retention
time were generated and uploaded to the instrument
acquisition software before data acquisition. For each
targeted data acquisition (TDA) experiment, a consis-
tency check was performed between the aligned reten-
tion times on the inclusion list and the experimental
retention times. If a significant shift (5 min), or a non
linear perturbation had occurred, the retention times
were realigned starting with the latest experiment as the
alignment seed and the inclusion list was updated.
Alignment of Retention Times
The two stage retention time alignment is used be-
cause we have noticed that experiments performed
on analytical separation columns of different lengths
(e.g., 20 cm versus 50 cm) or using slightly different
gradients have a non-negligible difference in the
order of which the peptides elute. Hence one would
first like to align all experiments done with the same
type of column, and then the experiments done with
other set ups. The ordering of alignments according
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care of this automatically.
An example comparing aligned retention times with
measured retention times is shown in the left part of
Figure 2. The green lines represent the applied retention
time window of15 min. The standard deviation of the
time differences between the aligned and measured
retention times is 1 min, which is a typical value
obtained using the applied retention time alignment
strategy. The average time shift is 0.74 min. We have
observed that the average time shift from experiment to
experiment has a standard deviation of 2–3 min for a
standard 4 h gradient provided that no changes to
the LC system are made between experiments. Hence
the precision (typical standard deviation of 1 min) of the
aligned retention time is better than the accuracy (av-
erage shift of 2–3 min). As a consequence, whenever
practical considerations do not allow updating of inclu-
sion lists for each run (e.g., when several runs are to be
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dem mass spectra was performed pointing to another
161 chromatographic peaks. M/z values determined for
these additional species all were within 7.5 ppm of the
m/z of the identified inclusion list peptides and reten-
tion times were all within 15 min from the respective
inclusion list peptides. These additional MS/MS spectra
either did not lead to any reliable peptide identifica-
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more, in 10 cases peptides from the inclusion list were
identified less than 15 min apart in retention time and
with m/z differences of less than 7.5 ppm. In a repeat
experiment with a retention time window of 30 min,
1016 peptides (58 less than in the 15 min window
experiment) were identified and MS/MS spectra point-
ing to 199 (38 more than in 15 min window experiment)
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sensitivity and selectivity of high mass accuracy inclu-
sion list experiments depend to a certain degree on the
inclusion mass retention time window that can be
achieved in day-to-day operation.
A particularly difficult case is shown in Figure
3a. Here two inclusion list peptides are identified,
ATNM(Ox)EFAVK, from RSK2 kinase, and ATNMEYAVK,
from RSK3 kinase. The two peptides have an identical
elemental composition and, hence, identical m/z values.
The retention time difference is less than four minutes.
This example illustrates that to detect as many peptides
as possible, a short dynamic exclusion time is required.
An accurate mass tag (AMT) [21, 22] strategy for
identifying two isomers spaced by four minutes would
have to rely on a retention time alignment with a
standard deviation of 1 min to distinguish the two
species with a 99% confidence.
Reproducibility of Peptide Identifications
Seven repeat experiments in shotgun and TDA mode
were performed on the reference sample using pulsed-
Q-dissociation. For TDA experiments, the inclusion
mass list contained 1534 peptides corresponding to 155
kinases. In total, 762 inclusion list peptides were de-
tected in shotgun mode and 961 peptides were detected
in targeted analysis mode representing 49.7% and 62.7%
of the inclusion list. Comparison of the generated
tandemmass spectra with the inclusion list showed that
in TDA mode the instrument almost exclusively (in
99.97% of the cases) selected precursors whosem/zwere
on the list and within the specified retention time
windows. For each detected inclusion list peptide fre-
quency of occurrence was calculated; 587 inclusion list
peptides were detected in seven out of seven experi-
ments in TDA mode compared with 206 in shotgun
mode (Figure 3b). Overall, the average peptide fre-
quency in shotgun experiments was 0.50 while for TDA
experiments the average peptide frequency was 0.82.
The peptide reproducibility achieved within a TDA
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complexity samples the reproducibility for TDA would
most likely have been higher.
The increase in peptide reproducibility corroborates
the observations of Jaffe et al. [20]. In this study, the
authors were able to detect peptides in plasma that
were difficult to detect with shotgun using a targeted
approach. In our experiments, typically 50% to 60% of
the inclusion list peptides were identified using the
targeted analysis approach. This relatively low number
might be attributed to two main factors. (1) To fully
explore the sensitivity gain possible with targeted data
acquisition, we included target proteins on the list, for
which chances of detection were very low (i.e., that
were detected only once in the 80 shotgun experiments
used to set up the inclusion list). (2) Whenever 10 or
fewer different peptides were detected for a specific
target protein in the reference dataset, we included all
peptides ever detected on the inclusion list, although
their frequency of occurrence in the reference dataset
might have been very low.
Multiple Fragmentation of Target Peptides
Multiple fragmentation of peptides by using high re-
peat count settings is usually omitted in shotgun exper-
iments because it is detrimental to protein coverage. To
illustrate this, we performed two shotgun experiments
back-to-back on a kinase enriched sample. We observed
a 20% drop in kinase identifications when the experi-
ment was performed with a repeat count of four as
compared with one, and quite remarkably a drop of
27% when only considering kinases quantified with at
least 4 spectra. In a typical shotgun run (repeat count 1)
8500 spectra were acquired identifying 4082 different
peptides. Since for targeted data acquisition only1500
different peptides were to be monitored, we explored
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
0
100
200
300
400
500
600
700
frequency of peptide identification
in 7 TA and SG experiments
# 
of
 in
cl
us
io
n 
lis
t p
ep
tid
es
(b)
eptides with different sequences, but identical
list peptides occurrence in seven shotgun (blue
ents is calculated as (# of experiments in which
or peptides that were seen at least once in either9
list p
lusion
erim
one fents.
1675J Am Soc Mass Spectrom 2010, 21, 1668–1679 TARGETED MS FOR IMPROVED QUANTIFICATIONthe use the free instrument acquisition time for per-
forming multiple fragmentations on the same precursor
to improve quantification of peptides on the inclusion
list.
In fact, when up to four repeat analyses per inclusion
list peptide were allowed for TDA experiments, on
average 30% fewer spectra were acquired in the tar-
geted analysis experiments (average number of spectra,
5711) than in shotgun experiments (average number of
spectra, 8160). The additional repeats also required less
instrument time than an average MS/MS spectrum
acquired in shotgun mode because the repeat fragmen-
tation events take place higher up the eluting chromato-
graphic peak (Figure 4a). On average, the first sequenc-
ing event was taking place 10 s before the apex of the
chromatographic peak, the second sequencing event 7 s
before, the third, 3 s before, and the fourth took place 1 s
after the apex. Hence, less ion accumulation time was
required to achieve the target ion value in the ion trap.
Figure 4b exemplifies this for one of the seven TDA
experiments. The median ion accumulation time value
for the first repeat was 218 ms, almost identical to
the median acquisition time for an MS/MS for one
of the seven shotgun experiments, 215 ms. The me-
dian of the second repeat was 179 ms, of the third 137
ms, and 119 ms for the fourth.
Co-fragmentation (fragmentation of other ions along
with the precursor ion of interest) affects the quantifi-
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repeat, violet for third repeat, and green for fourth rcation precision in iTRAQ based quantitative experi-
ments [23, 24]. To get an estimate on how much
co-fragmentation occurs for each peptide we developed
the signal-to-interference score (s2i). S2i is defined as
the ratio of the precursor ion intensities divided by the
total signal measured within the isolation window
applied (for details see the Methods section). A higher
s2i value translates to higher quantification precision.
This was evaluated by comparing two replicate TDA
experiments. In these, fold changes of peptides identi-
fied from precursors with an s2i score of 0.8 repro-
duced with an R2 value of 0.69. While the fold changes
of peptides from precursors with an s2i score of 0.8
reproduced with a much inferior R2 value of 0.40. This
clearly indicates that the s2i value is a good measure for
assessing the quantitation quality of a peptide.
The s2i was calculated for the precursors that were
sequenced four times and led to a reliable identification
of an inclusion list peptide (Figure 4c and d). The first
sequencing event that was performed at the start of the
chromatographic peak had a low average s2i of 0.571,
indicating substantial co-fragmentation. For the subse-
quent sequencing events increasingly higher signal-to-
interference (i.e., less co-fragmentation) values were
determined, going up to an average value of 0.756 for
the sequencing event corresponding to the fourth repeat
count. Hence, signal interference should be substan-
tially reduced for samples acquired using targeted data
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the shotgun approach where all sequencing events
behave like those corresponding to the first repeat
count. Note however that not all sequencing events
corresponding to the first repeat have low s2i. Out of
the 661 cases where a precursor was fragmented four
times (approximately 70% of all identified inclusion list
peptides), in 310 cases the fourth repeat had the highest
s2i, in 105 cases the third repeat, in 54 cases the second,
and in 37 cases the first, indicating that even though
statistically the s2i is on average at its highest at the top
of the chromatographic peak, there will be a significant
number of cases where there is a low s2i near the top of
the peak due to co-eluting fragments, but a high s2i at
the beginning of the peak due to the absence of co-
elution. This again demonstrates the benefit of having
multiple sequencing events across the chromatographic
peak.
Target Protein Coverage and Precision of
Quantification
Comparison of identified kinases for the seven shotgun
replicate analyses and the seven TDA experiments
indicated higher coverage and reproducibility using the
targeted data acquisition approach. The average num-
ber of identified kinases increased by 8.7 kinases using
the targeted approach (116 SG, 124.7 TA) with a stan-
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The number of kinases reproduced in all seven experi-
ments with at least four spectra was also higher in
targeted analysis than in shotgun, 104 versus 80
kinases (see supplementary Tables 1 and 2, which can
be found in the electronic version of this article). The
large increase of kinases quantified from four or more
spectra is partly because a 4 repeat count setting was
used. The average number of inclusion list peptides
identified in TDA experiments was 809.4 with a
standard error of 5.2.
Next, we calculated and compared the fold changes
of the identified kinases in two repeat experiments (two
for shotgun and two for TDA analyses) using the PQD
setup on the same instrument, to assess the precision of
quantification in the three approaches. One hundred
seven kinases were identified in both shotgun experi-
ments with at least one assigned spectrum. Comparison
of individual relative abundancies determined for each
kinase revealed a standard deviation of the log2 ratios of
the relative changes of 0.282 (Figure 5b) and an R2 value
of 0.50 (Figure 5c). In particular, the relative changes
determined for kinases quantified with few spectra (4
spectra) were poorly reproduced. In contrast, quantifi-
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in both experiments from at least four spectra repro-
duced substantially better (the 4 spectra requirement
for quantifying a protein is used in all our experiments).
For these 85 kinases, the R2 value was 0.78 and the
standard deviation of the log2 ratios of the relative
abundancies was 0.170 (cf. Figure 5b). Next we com-
pared two replicate TDA experiments. In total 118
(11 more than in shotgun) kinases were reproduced.
Amongst these, only six kinases were quantified with
less than four spectra. It should be noted that quantifi-
cation of these six kinases reproduced poorly just like in
the shotgun experiments (data not shown). A total of
112 (27 more than in shotgun) kinases quantified with
four or more quantified spectra were reproduced (Fig-
ure 5d). The R2 value was 0.82 and standard deviation
of the log2 ratios was 0.143. The relative abundancies of
the 85 kinases that were reproduced in the shotgun
experiments (marked in green in Figure 5d) had a R2
value of 0.92 and a standard deviation of 0.107 (Figure
5b), hence the quantification precision for these kinases
increased by more than 1.5-fold. The increase in kinase
identification in targeted analysis experiments com-
pared with shotgun experiments was due to the target-
ing of kinase-specific peptides on the inclusion list. The
data presented here clearly indicate that repeated ac-
quisition of tandem MS spectra for a given peptide
improves precision of quantification to a similar degree
as fragmentation and reporter ion based quantification
of additional different peptides. This explains the over-
all increase in precision of quantification observed
when the kinase enriched samples are analyzed using
targeted data acquisition. The pairwise comparisons of
the other experiments yielded very similar results.
CID/HCD Based iTRAQ Quantification Compared
with PQD
Recent versions of Orbitrap mass spectrometers have
been equipped with additional collision cells enab-
ling more triple-quadrupole-like fragmentation termed
HCD, thus omitting the low-mass cut-off generally
observed for resonance induced fragmentation on ion
trap instruments [25]. In a recent study using an
OrbitrapXL equipped with a octopole collision cell it was
shown that HCD provided more precise iTRAQ re-
porter ion based quantification than PQD on the spectra
level, but in a shotgun application was significantly
slower than PQD, which resulted in a lower number of
acquired spectra, fewer identified proteins and, overall,
in a very similar quantification precision as PQD on the
protein level [15]. Recently, Kocher and coworkers
reported on the combination of ion trap CID and
collision cell based HCD for sensitive and precise
identification and quantification of iTRAQ labeled sam-
ples [12]. In this approach, the CID spectra were used
for spectrum to sequence matching whereas HCD spec-
tra were acquired at elevated collision energies toachieve high yields of reporter ions facilitating precise
quantification. We have applied this approach for tar-
geted detection of kinase proteins in our proteomic
kinase assay, thereby evaluating if the required acqui-
sition of two spectra (CID and HCD) for each inclusion
list peptide would have any impact on kinase coverage.
In a first step, we optimized normalized collision
energy (NCE) for HCD so that as abundant as possible
reporter ions would be generated. Four targeted analy-
sis experiments using the CID/HCD setup were per-
formed with an inclusion list of 1534 peptides at four
different NCEs, 40%, 50%, 60%, 70%. The average
reporter ion area was calculated for the identified
peptides separated into three groups according to their
charge (Figure 6a). In agreement with Zhang et al. [26],
we observed that peptides in different charge states
have different NCE optima. The optimal values for
doubly charged ions were between 50% and 60% NCE,
while for 3 and 4 ions, a NCE of 70% was the best of
those tested. For 3 the optimal NCE is likely to be at
around 80% and for 4 at even higher values. In the 80
shotgun analyses acquired on kinase enriched samples,
doubly charged ions are the most predominant species.
Consequently, the majority of inclusion list peptides
were targeted as doubly charged species (67%) followed
by 3, 23% and 4 are rare with 3%. We chose the 70%
NCE value as a compromise, since it is located between
the best values for 2 and 3 and the average reporter
ion area for 2 drops by only 10% compared with the
60 NCE value. It is worth noting here that the instru-
ment method allows for selection of individual NCEs
for different peptides on the inclusion list. Unfortu-
nately, it is not possible to also set different NCEs for
CID and HCD, respectively. A potential solution to this
problem could be the use of an AMT strategy [21, 22] for
identifying the inclusion list peptides, which would
then eliminate the need for performing CID.
Two replicate TDA experiments using the CID/HCD
approach were performed on an Orbitrap XL and
compared with targeted analysis experiments using
PQD acquired on the same instrument. One hundred
twenty-four kinases quantified with at least four spectra
were reproduced (Figure 6b), (see supplementary Table
3). Correlation of quantification results between the two
CID/HCD experiments was excellent yielding an R2
value of 0.96 and a log2 standard deviation of 0.064
(Figure 6c). When considering only the 110 protein
kinases that were also reproducibly quantified with at
least 4 spectra in the back-to-back PQD experiments
(fold changes marked in blue in Figure 6b) R2 was as
high as 0.97 and a standard deviation of 0.054 was
achieved (Figure 6c). This demonstrates an 2-fold
higher quantification precision for the CID/HCD ap-
proach compared with PQD. The higher number of
identified and quantified kinases obtained from tar-
geted analysis experiments with the CID/HCD setup
(12 additional kinases) is likely due to the in average
better quality of spectra acquired with CID as compared
with PQD enabling improved protein identification.
1678 SAVITSKI ET AL. J Am Soc Mass Spectrom 2010, 21, 1668–1679The precision increase of kinase quantification from
TDA experiments with the PQD setup to TDA experi-
ments with the CID/HCD setup can mainly be attrib-
uted to the better ion statistics for reporter ions in the
MS/MS spectra performed in HCD mode. These obser-
vations agree with Kocher et al. [12].
Inter-Instrument Reproducibility
High reproducibility in repeat back-to-back experi-
ments on the same mass spectrometer is a good mea-
sure for precision. However, a quantification based
proteomic assay should ideally reproduce equally well
when the sample is applied on different mass spectrom-
eters, thus excluding a mass spectrometer specific bias.
To assess inter-instrument reproducibility of the quan-
titative readout, we analyzed the iTRAQ reference
sample on two similar but slightly different Orbitrap
mass spectrometers (Orbitrap XL and the newer Orbi-
trap Velos) that were coupled to different Eksigent
NanoLCs using the targeted analysis method with the
CID/HCD setup. One hundred twenty-three kinases
with at least four spectra were reproduced, and their
measured relative abundancies compared (Figure 6d);
the R2 value was 0.94 and the standard deviation of the
log2 ratios of the determined fold changes was 0.090.
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of the fitted line was 0.95 and the intercept was 0.05.
This indicates a very lowmass spectrometer/LC system
specific bias, which in turn is indicative of not only high
precision, but also of good accuracy.
Conclusions
We have developed a targeted mass spectrometric data
acquisition methodology that is useful in applications
where it is essential to re-identify and re-quantify a
defined set of target proteins in a complex sample. We
have successfully applied this strategy to the quantita-
tive detection of a set of more than 100 protein kinases
in an affinity-captured subproteome. The targeted ap-
proach outperforms the standard shotgun approach in
terms of identification numbers and quantification pre-
cision. In addition, it is shown that the targeted data
acquisition approach is compatible with a dual peptide
fragmentation strategy using CID for generation of
backbone fragments, facilitating peptide identifications
and HCD for improved reporter ion based quantifica-
tion. This approach yielded a higher identification rate
and more precise quantification compared with targeted
peptide fragmentation using pulsed-Q-dissociation. Con-
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1679J Am Soc Mass Spectrom 2010, 21, 1668–1679 TARGETED MS FOR IMPROVED QUANTIFICATIONdata repositories [27, 28], and the improving tools for
prediction of proteotypic peptides [29, 30], we antici-
pate that generation of appropriate inclusion mass lists
for any given sample will be largely simplified, requir-
ing acquisition of less experimental data.
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